梧州招聘

1. Development and execution of scientific communication Plan and strategies:
?Develop and execute scientific communication plans and strategies to support TA strategies and IPS strategis.
?Alignment and update Scientific communication plan and training plan in TATC,FST and FMT with MSL,Head of MSL and TA Leaders,
2. Knowledge management
?Execute and responsible for Knowledge management through innovative and efficient platform as Sharepoints, book series et al.
?Responsible for all TA and Brand-related scientific communication with internal customers
?External vender management on development scientific materials and tools.Accountable for the content of scientific materials, ensuring comprehensive, high quality and compliance..
?Responsible for the consolidation and distributionof brand-specific key messages and related materials and tools such as scientific slides resources,articles and publications.
?Consolidate all publications and presentations of whole medical Unit(Franchise) to sharepoint with Final quality checks.
3. Internal Scientific Training
?Understanding the needs and gaps of internal staff,including MSL,MA,KAM,FF et and develop TA training Curriculium with yearly update.
?Responsible for New On boarding TA knowledge training and certification.
?Training materials management: prepare, organize and manage training materials according to different roles and needs.
?Prepare and finalize internal training modules/solutions.

北京诺华制药有限公司开发、生产和销售治疗多种疾病的创新处方药，涵盖的疾病领域包括：心血管、内分泌、肿瘤、抗感染、风湿疼痛及骨质疏松、移植免疫、中枢神经以及眼科。北京诺华制药曾获得“***雇主”和“最负社会责任的企业”等殊荣。

“诺华”中文取意“承诺中华”，即承诺通过不断创新的产品和服务致力于提高中国人民的健康水平和生活质量。北京诺华制药成立于1987年，总部设在北京，隶属于瑞士诺华公司。

诺华公司致力于为患者及社会提供创新医药保健解决方案，以满足其日益变化的健康需求。2011年，集团持续经营业务实现净销售586亿美元。集团研发投入约为96亿美元（去除减值及摊销后为92亿美元）。诺华集团总部位于瑞士巴塞尔，业务遍及全球140多个国家和地区，拥有124,000位全职员工。诺华集团立足在中国的长期发展，重要战略投资包括位于上海的综合性生物医学研发中心，以及位于北京昌平的制剂生产工厂和江苏常熟的原料药生产工厂。如需更多信息，敬请登录公司网站http://www.novartis.com和http://www.novartis.com.cn。